Small molecule inhibitors of bacterial toxins
AssigneeArtizan Biosciences
InventorsWilliam HOEKSTRA, Hyunji RYU, Priyanka CHINTHA
Life of this patent
Estimating the term…
Abstract
Described herein are compounds and compositions for use in treatment or prevention of an inflammatory bowel disease, gastrointestinal cancer, or a systemic bacterial infection in a subject in need thereof. The subject may be colonized by one or more pathogenic bacterial strains such as B. fragilis, E. faecalis, or C. perfringens. In certain aspects, the disclosure provides a method of diminishing the pathogenic effects of these bacterial strains by administering a compound that binds to and/or inhibits one or more toxins produced thereby.
Claims30
A compound of Formula III:
- or a pharmaceutically acceptable salt or stereoisomer thereof,
- wherein:
- X is —NH—;
- Y is —OH;
- R1 is —C1-C6 alkyl, —C1-C6 alkylene-OH, —(C1-C3 alkylene)-O—(C1-C3alkyl), —(C1-C3 alkylene)-S—(C1-C3alkyl), —(C1-C3 alkylene)-S—(C1-C3 haloalkyl), or phenyl, wherein the phenyl is optionally substituted with one or more groups selected from —OH, —OMe, halogen, —CHF2, —CH2F, and —CF3;
- R2 is —(CH2)2-aryl or —(CH2)2-heteroaryl;
- and
- R3 is H.
A compound having the structure:
- or a pharmaceutically acceptable salt or stereoisomer thereof.
Dependencies are inferred from the claim text.